You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

IPSS-R very low/IPSS-R low/IPSS-R intermediate

Showing 51 - 75 of >10,000
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

MDS Trial in Beijing (Hetrombopag, Stanozolol Tablets)

Not yet recruiting
  • MDS
  • Beijing, China
    Peking Union Medical College Hospital
Sep 18, 2021

Myelodysplastic Syndrome, MDS Trial in Gainesville, Tampa (Prednisone, Lenalidomide)

Completed
Has Results
  • Myelodysplastic Syndrome
  • MDS
  • Gainesville, Florida
  • +1 more
Dec 10, 2019

MDS Trial in Germany (Luspatercept)

Recruiting
  • Myelodysplastic Syndromes
  • Hamburg, Germany
  • +4 more
Dec 20, 2021

BPH (Benign Prostatic Hyperplasia), Lower Urinary Tract Symptoms (LUTS) Trial in New York, Salt Lake City (Butterfly Prostatic

Recruiting
  • BPH (Benign Prostatic Hyperplasia)
  • Lower Urinary Tract Symptoms (LUTS)
  • Butterfly Prostatic Retraction Device
  • New York, New York
  • +1 more
May 31, 2022

Acute Myeloid Leukemia Trial in Suzhou (CAV Regimen, MEC Regimen)

Recruiting
  • Acute Myeloid Leukemia
  • CAV Regimen
  • MEC Regimen
  • Suzhou, Jiangsu, China
    The First Affliated Hospital of Soochow University
Dec 22, 2022

Lymphoma, Large B-Cell, Diffuse Trial in Worldwide (Durvalumab, Rituximab, Doxorubicin)

Completed
Has Results
  • Lymphoma, Large B-Cell, Diffuse
  • Gilbert, Arizona
  • +18 more
Aug 19, 2022

Mean Platelet Volume and Its Relation to Risk Stratification of

Completed
  • Myelodysplastic Syndromes
    • (no location specified)
    Jan 21, 2022

    Prostate Cancer, Prostate Adenocarcinoma Trial in Canada, United States (Radical Prostatectomy, TULSA Procedure)

    Recruiting
    • Prostate Cancer
    • Prostate Adenocarcinoma
    • Radical Prostatectomy
    • TULSA Procedure
    • Tarzana, California
    • +7 more
    Aug 10, 2022

    Prostate Cancer Trial (SUPR-SABR treatment)

    Not yet recruiting
    • Prostate Cancer
    • SUPR-SABR treatment
    • (no location specified)
    Dec 20, 2022

    Low Risk Papillary Thyroid Cancer

    Recruiting
    • Papillary Thyroid Cancer
    • +2 more
      • Halifax, Nova Scotia, Canada
      • +4 more
      Feb 3, 2021

      AL Amyloidosis Trial in Catanzaro, Pavia, Rome (daratumumab and pomalidomide)

      Recruiting
      • AL Amyloidosis
      • daratumumab and pomalidomide
      • Catanzaro, Italy
      • +2 more
      Aug 3, 2022

      Lower Urinary Tract Symptoms, Prostatic Hyperplasia, Prostatic Cancer Trial in Madrid (Temporary prostatic stent (Exime®),

      Not yet recruiting
      • Lower Urinary Tract Symptoms
      • +3 more
      • Temporary prostatic stent (Exime®)
      • Indwelling catheter
      • Madrid, Spain
        Juan Ignacio Martinez-Salamanca
      May 1, 2023

      MDS Trial in Japan (Eltrombopag, Placebo)

      Recruiting
      • Myelodysplastic Syndromes
      • Narita, Chiba, Japan
      • +21 more
      Jan 19, 2023

      Hematological Malignancies Trial in United Kingdom, United States (Magrolimab, Azacitidine)

      Active, not recruiting
      • Hematological Malignancies
      • Duarte, California
      • +26 more
      Dec 7, 2022

      Acute Myeloid Leukemia Trial in Kunming (CLL1 and CD38 dual-target CAR-T injection)

      Recruiting
      • Acute Myeloid Leukemia
      • CLL1 and CD38 dual-target CAR-T injection
      • Kunming, Yunnan, China
        920th Hospital of Joint LogisticsSupport Force of People's Liber
      Oct 26, 2023

      Diffuse Large B Cell Lymphoma, Relapse/Recurrence, Extranodal Extension Trial in Beijing (Low-Dose Decitabine plus anti-PD-1)

      Recruiting
      • Diffuse Large B Cell Lymphoma
      • +3 more
      • Low-Dose Decitabine plus anti-PD-1
      • Beijing, Beijing, China
        ChinaPLAGH
      Apr 18, 2023

      DLBCL Trial in Suzhou (Chidamide, Azacitidine, obinutuzumab)

      Recruiting
      • Diffuse Large B-Cell Lymphoma
      • Suzhou, Jiangsu, China
        the First Affiliated Hospital of Soochow University
      Apr 10, 2023

      Diffuse Large B-cell Lymphoma Trial in Shanghai (Rituximab, Cyclophosphamide, Epirubicin)

      Active, not recruiting
      • Diffuse Large B-cell Lymphoma
      • Shanghai, Shanghai, China
        Shanghai Ruijin Hospital
      Dec 1, 2022

      PD-1 Refractory Advanced Melanoma Trial in Pittsburgh (Responder-Derived Fecal microbiota transplantation (R-FMT, Pembrolizumab,

      Not yet recruiting
      • PD-1 Refractory Advanced Melanoma
      • Responder-Derived Fecal microbiota transplantation (R-FMT
      • +2 more
      • Pittsburgh, Pennsylvania
        UPMC Hillman Cancer Center
      Sep 1, 2023

      Social Isolation, Loneliness, Geriatric Trial in Toronto (Intergenerational HOW R U?, Same-Generation Peer Support HOW R U?)

      Recruiting
      • Social Isolation
      • +2 more
      • Intergenerational HOW R U?
      • Same-Generation Peer Support HOW R U?
      • Toronto, Ontario, Canada
        Mount Sinai Hospital
      Aug 16, 2023

      AML, MDS Trial in Tianjin (XZB-0004)

      Not yet recruiting
      • AML
      • MDS
      • Tianjin, Tianjin, China
        Hematology Hospital, Chinese Academy of Medical Sciences
      Feb 13, 2023

      Relapsed/Refractory Large B-cell Lymphoma Trial (KITE-197, Cyclophosphamide, Fludarabine)

      Not yet recruiting
      • Relapsed/Refractory Large B-cell Lymphoma
      • (no location specified)
      Oct 6, 2023

      MDS Trial in Miami, New York (50 gm CIVI/24 hours x 5 days every 4 week)

      Recruiting
      • Myelodysplastic Syndromes
      • 50 gm CIVI/24 hours x 5 days every 4 week
      • Miami, Florida
      • +1 more
      Jul 6, 2022

      Radiotherapy, Breast Cancer, Relaxation Trial in Munich (Respiratory training and relaxation techniques under adjuvant radiation

      Recruiting
      • Radiotherapy
      • +3 more
      • Respiratory training and relaxation techniques under adjuvant radiation therapy in DIBH in breast cancer
      • Munich, Germany
        Department of Radiation Oncology, Technical University of Munich
      Aug 1, 2023

      Relapsed/Refractory Waldenstrom Macroglobulinemia, Relapsed/Refractory Richter Transformation, Relapsed/Refractory Burkitt

      Not yet recruiting
      • Relapsed/Refractory Waldenstrom Macroglobulinemia
      • +3 more
      • Brexucabtagene Autoleucel
      • +2 more
      • (no location specified)
      Sep 8, 2022